. Author manuscript; available in PMC: 2021 Aug 1.

Published in final edited form as: Am J Obstet Gynecol. 2020 Feb 20;223(2):234.e1–234.e8. doi: 10.1016/j.ajog.2020.02.008

Table 2A.

Primary surgical indications for minimally invasive non-hysterectomy procedures in CPC vs. ERAS

Indication	CPC (n = 214)	ERAS (n = 196)	P-value
Pelvic Pain – Endometriosis	104 (48.6)	97 (49.5)	.857
Pelvic Pain – Non-Endometriosis	47 (22.0)	18 (9.2)	<.001
Fibroids	6 (2.8)	17 (8.7)	.010
Infertility	2 (0.9)	2 (1.0)	>.999
Sterilization	6 (2.8)	6 (3.0)	.877
Adnexal Cyst/Mass	43 (20.1)	47 (24.0)	.342
Foreign Body	1 (0.5)	0 (0.0)	.338
Prophylactic/ Breast Cancer	5 (2.3)	9 (4.6)	.209

CPC, conventional peri-operative care; ERAS, enhanced recovery after surgery; Data are n (%)